Heat Biologics (HTBX) Begins Dosing in HS-410 Phase 1 as Bladder Cancer Treatment
Tweet Send to a Friend
Heat Biologics (NASDAQ: HTBX) has dosed the ninth and final patient required in the Phase 1 portion of its Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
